Assessment of Glioblastoma Response in the Era of Bevacizumab: Longstanding and Emergent Challenges in the Imaging Evaluation of Pseudoresponse-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Assessment of Glioblastoma Response in the Era of Bevacizumab: Longstanding and Emergent Challenges in the Imaging Evaluation of Pseudoresponse

Published:2019-05-07 Issue: Volume:10 Page:
ISSN:1664-2295
Container-title:Frontiers in Neurology
language:
Short-container-title:Front. Neurol.

Author:

Arevalo Octavio D.,Soto Carolina,Rabiei Pejman,Kamali Arash,Ballester Leomar Y.,Esquenazi Yoshua,Zhu Jay-Jiguang,Riascos Roy Francisco

Publisher

Frontiers Media SA

Subject

Clinical Neurology,Neurology

Reference86 articles.

1. Consensus recommendations for a standardized brain tumor imaging protocol in clinical trials;Ellingson;Neuro-oncology.,2015

2. Glioblastoma multiforme - an overview;Urbanska;Contemp Oncol,2014

3. Microvessel density is a prognostic indicator for patients with astroglial brain tumors;Leon;Cancer.,1996

4. Descriptive analysis and quantification of angiogenesis in human brain tumors;Folkerth;J Neurooncol.,2000

5. MRI enhancement and microvascular density in gliomas. Correlation with tumor cell proliferation;Tynninen;Invest Radiol.,1999

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Use of Apparent Diffusion Coefficient Values for Differentiating Bevacizumab-Related Cytotoxicity from Tumor Recurrence and Radiation Necrosis in Glioblastoma;Cancers;2024-07-02

2. Pembrolizumab in an HIV-infected patient with glioblastoma;Immunotherapy;2024-06-18

3. A non-enhancing, T2 fluid-attenuated inversion recovery hyperintense, diffusion-restricting brainstem lesion in an EGFR tyrosine kinase inhibitor-treated non-small-cell lung cancer patient;Biomarkers in Medicine;2024-05-02

4. Artificial intelligence-based MRI radiomics and radiogenomics in glioma;Cancer Imaging;2024-03-14

5. Amino acid PET vs. RANO MRI for prediction of overall survival in patients with recurrent high grade glioma under bevacizumab therapy;European Journal of Nuclear Medicine and Molecular Imaging;2024-01-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3